VivoSeq
Other

Chronic

0

Pipeline Programs↗

8

Active Trials↗

17

Companies Involved↗

Chronic is an early-stage landscape with 0 programs across 17 companies. The most active players are Boehringer Ingelheim, Gilead, Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

78/100

Attrition Rate

16/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Boehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalGilead logo

Gilead

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalB

Bukwang Pharmaceutical

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalNovartis logo

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

107

clinical trials

Completed68 · 64%
Terminated14 · 13%
Unknown status11 · 10%
Recruiting3 · 3%
Active, not recruiting3 · 3%
Withdrawn3 · 3%
Other5 · 5%

Clinical Trials

Trial Activity

107 trials

Sildenafil for Microvasculopathy in Chronic TBI
Recruiting·UUniversity of Pennsylvania·Phase 2·NCT05782244·160 enrolled
Chronic Intestinal Pathologies Analytical Cohort at TouLouse
Recruiting·UUniversity Hospital, Toulouse·N/A·NCT04896684·300 enrolled
Movement Amplification Gait Training to Enhance Walking Balance Post-Stroke
Recruiting·VVA Office of Research and Development·Preclinical·NCT06400186·30 enrolled
Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan
Active, not recruiting·Sanofi logoSanofi·Phase 3·NCT07216079·4 enrolled
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Active, not recruiting·VVA Office of Research and Development·Phase 2·NCT04232657·36 enrolled
Comparative Effects of Coordinative Locomotor Training Using Sprinter Versus Skater Coordination Synergies on Balance and Coordination in Patients With Chronic Stroke: A Randomized Clinical Trial
Active, not recruiting·UUniversity of Faisalabad·Preclinical·NCT07658495·22 enrolled
Jianzhong Qushi in Chronic RRI
Not yet recruiting·—·Phase 3·NCT06837597·168 enrolled
Effects of a Protocol of Hip Flexor Stretching on Chronic Mechanical, Non-specific LBP.
Not yet recruiting·—·N/A·NCT06975345·100 enrolled
Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients
Completed·—·Phase 1·NCT02413645·21 enrolled
Improving Ventilatory Capacity in Those With Chronic High Level SCI
Completed·SSpaulding Rehabilitation Hospital·Phase 2·NCT05041322·13 enrolled
Effects of Temazepam in Patients With Chronic Pulmonary Obstructive Disease
Completed·RRijnstate Hospital·Phase 3·NCT00245661·14 enrolled
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV
Completed·Gilead logoGilead·Phase 2·NCT00725803·33 enrolled
Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)
Completed·Takeda logoTakeda·Phase 3·NCT00261300·100 enrolled
The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions
Completed·JJohns Hopkins University·Phase 1·NCT04283019·75 enrolled
OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients
Completed·MMundipharma (China) Pharmaceutical Co. Ltd·Phase 1·NCT02880475·30 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)